Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension.
about
Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators.Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).Treatment of scleroderma: an update.A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonismNitric oxide donor drugs: an update on pathophysiology and therapeutic potential.
P2860
Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@ast
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@en
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@nl
type
label
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@ast
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@en
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@nl
prefLabel
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@ast
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@en
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@nl
P2093
P2860
P1476
Therapeutic potential of endot ...... ors in pulmonary hypertension.
@en
P2093
P2860
P304
P356
10.1517/13543784.10.7.1291
P407
P577
2001-07-01T00:00:00Z